New capability delivers end-to-end traceability across all product development data, connecting milestones, decisions, and evidence across every phase of the medical device lifecycle. In an era of ...
The FDA is already reviewing with AI. Most device makers' evidence wasn't built for that. Enlil's four-layer architecture grounds AI in a unified system of record, so every AI-assisted answer and ...
At the core of Enlil's offering is its use of AI-powered intelligence, including a private large language model (LLM)–driven chatbot. By embedding secure, contextual AI into its platform, Enlil's ...
CAMPBELL, Calif., May 14, 2026 /PRNewswire/ -- Enlil, the AI-powered development traceability platform built for medical device and life sciences organizations, today announced a record first quarter ...
Newswise — CAMPBELL, Calif., March 4, 2025 - Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated product companies with its comprehensive development traceability platform, ...
Enlil was founded to solve a critical challenge for medical device innovators: efficiently navigating regulated product development without being hindered by disconnected systems, manual processes, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results